Chunlizhengda Medical Instruments engages in structured deposit transactions

Beijing Chunlizhengda Medical Instruments Co. has announced several structured deposit transactions, leveraging temporary idle funds. On September 26, 2025, the company subscribed to a structured deposit product from SPD Bank for 85m yuan, utilizing internal resources. This product, linked to the EUR/USD exchange rate, offered an expected annualized return between 0.70% and 2.25% over a 22-day term.

Additionally, on November 11, 2025, Chunlizhengda entered into three more agreements. These include two structured deposit products with Bank of Beijing for 290m yuan and 210m yuan, respectively, using temporary idle proceeds from A share issuance. A third agreement with Bank of Beijing involved 290m yuan from internal resources. These Bank of Beijing products, maturing on May 18, 2026, are linked to the EUR/USD rate with annualized returns of 1.20% or 1.90% over 186 days.

These transactions, when aggregated, represent discloseable transactions under Chapter 14 of the Listing Rules, with applicable percentage ratios exceeding 5% but remaining below 25%, thus exempting them from shareholders' approval. The company stated that the SPD Structured Deposit Products Agreement and the Bank of Beijing Structured Deposit Products Agreements had been fully redeemed prior to this announcement.